Tech Company Financing Transactions
Meditrina Pharmaceuticals Funding Round
On 10/3/2019, Meditrina Pharmaceuticals raised $13 million in financing from Aethan Capital, Shangbay Capital and private investors.
Transaction Overview
Company Name
Announced On
10/3/2019
Transaction Type
Venture Equity
Amount
$13,000,000
Round
Undisclosed
Investors
Aethan Capital (Lead Investor)
Shangbay Capital (Lead Investor)
Proceeds Purpose
The company intends to use the proceeds to launch the US commercialization of the Aveta System that received U.S. Food and Drug Administration (FDA) 510(k) clearance in May 2019.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1190 Saratoga ave. 180
San Jose, CA 95129
USA
San Jose, CA 95129
USA
Phone
Website
Email Address
Not Recorded
Overview
Meditrina Pharmaceuticals, Inc. identifies and repurposes already marketed therapies and product candidates at advanced stages of development for new indications focused on improving women's health disorders with unmet medical needs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Csaba Truckai
Browse more venture capital transactions:
Prev: 10/3/2019: ControlRad venture capital transaction
Next: 10/3/2019: Aero venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs